SE447699B - Sett att framstella en antiprotozoisk och antibakteriell veterinermedicinsk komposition omfattande trimetoprim och sulfakinoaxalin - Google Patents
Sett att framstella en antiprotozoisk och antibakteriell veterinermedicinsk komposition omfattande trimetoprim och sulfakinoaxalinInfo
- Publication number
- SE447699B SE447699B SE7804176A SE7804176A SE447699B SE 447699 B SE447699 B SE 447699B SE 7804176 A SE7804176 A SE 7804176A SE 7804176 A SE7804176 A SE 7804176A SE 447699 B SE447699 B SE 447699B
- Authority
- SE
- Sweden
- Prior art keywords
- sulfaquinoxaline
- trimethoprim
- veterinary
- composition
- present
- Prior art date
Links
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 title claims description 38
- 239000000203 mixture Substances 0.000 title claims description 37
- 229960001082 trimethoprim Drugs 0.000 title claims description 34
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 4
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 claims description 35
- 229960003097 sulfaquinoxaline Drugs 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 10
- 235000014666 liquid concentrate Nutrition 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- -1 alkali metal salt Chemical class 0.000 claims description 4
- 230000000842 anti-protozoal effect Effects 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 239000003904 antiprotozoal agent Substances 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 19
- 241000287828 Gallus gallus Species 0.000 description 16
- 235000013330 chicken meat Nutrition 0.000 description 13
- 244000144977 poultry Species 0.000 description 10
- 235000013594 poultry meat Nutrition 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 9
- 239000003651 drinking water Substances 0.000 description 8
- 235000020188 drinking water Nutrition 0.000 description 8
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000003495 Coccidiosis Diseases 0.000 description 5
- 206010023076 Isosporiasis Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- LDBTVAXGKYIFHO-UHFFFAOYSA-N diaveridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=CN=C(N)N=C1N LDBTVAXGKYIFHO-UHFFFAOYSA-N 0.000 description 4
- 229950000246 diaveridine Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 210000003250 oocyst Anatomy 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 208000021017 Weight Gain Diseases 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 3
- 238000011886 postmortem examination Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940124530 sulfonamide Drugs 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 241000223931 Eimeria acervulina Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 210000004712 air sac Anatomy 0.000 description 2
- GNMOPZKSTPABSN-UHFFFAOYSA-N dimethoxymethane;propane-1,2,3-triol Chemical compound COCOC.OCC(O)CO GNMOPZKSTPABSN-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- SOHAVULMGIITDH-ZXPSTKSJSA-N (1S,9R,14E)-14-(1H-imidazol-5-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione Chemical compound C([C@]1(C2=CC=CC=C2N([C@@]21NC1=O)OC)C(C)(C)C=C)=C(OC)C(=O)N2\C1=C\C1=CNC=N1 SOHAVULMGIITDH-ZXPSTKSJSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 241000499566 Eimeria brunetti Species 0.000 description 1
- 241000223934 Eimeria maxima Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SOHAVULMGIITDH-UHFFFAOYSA-N Oxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)C=C(OC)C(=O)N2C1=CC1=CN=CN1 SOHAVULMGIITDH-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000014483 powder concentrate Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- XOXHILFPRYWFOD-UHFFFAOYSA-N sulfachloropyridazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=C(Cl)N=N1 XOXHILFPRYWFOD-UHFFFAOYSA-N 0.000 description 1
- 229950008831 sulfachlorpyridazine Drugs 0.000 description 1
- 229940072176 sulfonamides and trimethoprim antibacterials for systemic use Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB15459/77A GB1596044A (en) | 1977-04-14 | 1977-04-14 | Veterinary compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7804176L SE7804176L (sv) | 1978-10-15 |
| SE447699B true SE447699B (sv) | 1986-12-08 |
Family
ID=10059514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7804176A SE447699B (sv) | 1977-04-14 | 1978-04-13 | Sett att framstella en antiprotozoisk och antibakteriell veterinermedicinsk komposition omfattande trimetoprim och sulfakinoaxalin |
Country Status (31)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3266202D1 (en) * | 1981-09-23 | 1985-10-17 | Hoffmann La Roche | Manufacturing process of sulfonamide-potentiator solutions and a new sulfanilamide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1108112A (en) * | 1965-03-04 | 1968-04-03 | Wellcome Found | Compositions containing sulphaquinoxaline and diaveridine for use in veterinary medicine |
| BE787236A (fr) * | 1971-08-05 | 1973-02-05 | Wellcome Found | Compositions de potentialisation |
| GB1469521A (en) * | 1973-01-05 | 1977-04-06 | Wellcome Found | Antimicrobial preparations |
-
1977
- 1977-04-14 GB GB15459/77A patent/GB1596044A/en not_active Expired
-
1978
- 1978-04-11 PH PH20988A patent/PH16537A/en unknown
- 1978-04-13 AU AU35059/78A patent/AU517041B2/en not_active Expired
- 1978-04-13 NZ NZ186967A patent/NZ186967A/xx unknown
- 1978-04-13 IT IT48884/78A patent/IT1102594B/it active
- 1978-04-13 FR FR7810874A patent/FR2387036A1/fr active Granted
- 1978-04-13 GR GR55964A patent/GR65955B/el unknown
- 1978-04-13 NO NO781295A patent/NO781295L/no unknown
- 1978-04-13 ES ES468750A patent/ES468750A1/es not_active Expired
- 1978-04-13 MC MC781294A patent/MC1187A1/xx unknown
- 1978-04-13 ZA ZA00782128A patent/ZA782128B/xx unknown
- 1978-04-13 CH CH397178A patent/CH639275A5/de not_active IP Right Cessation
- 1978-04-13 JP JP4374678A patent/JPS53130439A/ja active Granted
- 1978-04-13 BE BE186781A patent/BE865964A/xx not_active IP Right Cessation
- 1978-04-13 AR AR271771A patent/AR216319A1/es active
- 1978-04-13 ZM ZM40/78A patent/ZM4078A1/xx unknown
- 1978-04-13 IE IE730/78A patent/IE46866B1/en not_active IP Right Cessation
- 1978-04-13 DE DE19782816064 patent/DE2816064A1/de active Granted
- 1978-04-13 SE SE7804176A patent/SE447699B/sv not_active IP Right Cessation
- 1978-04-13 DK DK7162078A patent/DK162078A/da not_active IP Right Cessation
- 1978-04-13 CA CA301,104A patent/CA1103162A/en not_active Expired
- 1978-04-13 NL NL7803917A patent/NL7803917A/xx unknown
- 1978-04-13 HU HU78WE574A patent/HU181027B/hu unknown
- 1978-04-13 FI FI781129A patent/FI781129A7/fi not_active Application Discontinuation
- 1978-04-13 LU LU79429A patent/LU79429A1/xx unknown
- 1978-04-13 PT PT67903A patent/PT67903B/pt unknown
- 1978-04-14 CY CY1260A patent/CY1260A/en unknown
-
1984
- 1984-07-16 KE KE3418A patent/KE3418A/xx unknown
- 1984-08-01 SG SG533/84A patent/SG53384G/en unknown
- 1984-11-01 HK HK850/84A patent/HK85084A/en not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY261/85A patent/MY8500261A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Houssay et al. | Experimental diabetes and diet | |
| ES341127A1 (es) | Un procedimiento para la preparacion de nuevas 1,2,3,4-te- trahidro-9-amino-acridinas. | |
| US2544826A (en) | Anthelmintic feed composition | |
| US3436459A (en) | Fat soluble vitamin compositions | |
| SE447699B (sv) | Sett att framstella en antiprotozoisk och antibakteriell veterinermedicinsk komposition omfattande trimetoprim och sulfakinoaxalin | |
| GB1252088A (enrdf_load_stackoverflow) | ||
| US3558778A (en) | Methods and compositions for use in animal husbandry | |
| GB1337860A (en) | Nitrodiphenyl ether derivatives and their use as herbicides | |
| ELLIOTT et al. | Relative effect of vitamin D and parathyroid extract on plasma calcium and citric acid of normal and thyroparathyroidectomized dogs | |
| US3123528A (en) | New therapeutic compositions | |
| GB1574105A (en) | Antimalarial compositions containing quinoline methanol derivatives | |
| US3364110A (en) | Method for preventing coccidiosis with certain benzohydroxamic acid derivatives | |
| Roe | Effect of massive doses of riboflavin, and other vitamins of the B group, on skin carcinogenesis in mice | |
| US2823160A (en) | Substituted pyrimidines compositions for chemotherapy of coccidiosis | |
| US3761594A (en) | Composition for control of coccidiosis containing a coccidiostiatically active 4-hydroxy-quinoline and meticlorpindol | |
| US2914446A (en) | Nitrite stabilized ascorbic acid-cyanocobalamin compositions | |
| US3519712A (en) | Therapeutic compositions comprising n-methylglucamine and coumermycin or salts thereof | |
| US2385468A (en) | Monoalkyl ethers of diethylstilboestrol | |
| Campbell | Sodium chloride as an adjunct to a diet of whole wheat and whole milk | |
| US2319094A (en) | Organic chemical product | |
| US3211612A (en) | Anticoccidial compositions and method of using same | |
| Ball et al. | Anticoccidial activity of nicotinamide antagonists | |
| US3160559A (en) | Method of controlling fungus infections with 3-halogeno-4-nitro-6-lower alkylpyridazine-1-oxide | |
| US3357886A (en) | Oral antiseptic composition containing 1, 3, 7-triazabicyclo [3. 3. 0] octanes | |
| US3658960A (en) | Compositions containing 1 3-dicyanotetrachlorobenzene used in coccidiosis treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7804176-1 Effective date: 19941110 Format of ref document f/p: F |